More than half of the hospital infections are caused by the use of medical devices such as catheters and implants. Dutch biotech startup LipoCoat wants to fight these life-threatening bacterial infections in hospital environments and has now secured funding of €1.5 million amid coronavirus outbreak.
The funding comes from Dutch informal investors, the High Tech Fund from Enschede and Innovation Fund Rabobank. The funding will allow LipoCoat to bring innovations in infection control to market faster.